(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

IMMUNOCLEAR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

IMMUNOCLEAR

ST13

US500000097149058

Class

44

Filing

97149058

Registration

7295240

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

01/30/2024

Trademark type

Word

Nice classes

44

Filing date

11/30/2021

Registration date

01/30/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

01/30/2024

Last transaction

01/30/2024

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2022-03-00

First use in commerce

2022-03-00

Drawing code

4

Owner type

03

Owner location

HOMEWOOD, AL, US

Examiner

HUSSAIN, TASNEEM

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

CIRCULOGENE THERANOSTICS, INC.
Circulogene Theranostics, LLC

Representatives

Nicholas J. Landau MAYNARD NEXSEN PC

Technical classification

Nice Classes

Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 44

Medical testing for diagnostic or treatment purposes

Publications

History of USPTO decisions and trademark events.

28 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

01/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

01/30/2024

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

12/23/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

12/22/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/16/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

12/14/2023

IUAF

USE AMENDMENT FILED

12/05/2023

EISU

TEAS STATEMENT OF USE RECEIVED

12/05/2023

DOCK

ASSIGNED TO EXAMINER

11/30/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/29/2023

EX1G

SOU EXTENSION 1 GRANTED

06/27/2023

EXT1

SOU EXTENSION 1 FILED

06/27/2023

EEXT

SOU TEAS EXTENSION RECEIVED

06/27/2023

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/11/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/11/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/11/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/11/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/11/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/11/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/03/2023

ASGN

AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP

11/25/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/08/2022

PUBO

PUBLISHED FOR OPPOSITION

11/08/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/19/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/02/2022

DOCK

ASSIGNED TO EXAMINER

09/09/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

12/03/2021

NWAP

NEW APPLICATION ENTERED

12/03/2021

Continuous trademark protection

Get notified about every new filing that threatens IMMUNOCLEAR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.